RE:RE:Share PriceIt should be obvious as to why MDMA is going up. In only a few months they have signed agreements with a number of high profile hospitals and universities (John Hopkins, Mt. Sinai, Harvard, Yale, Texas University) I'm sure there are many more agreements on the horizon. Similar company's in the sector have market caps between 250 million to over 600 million. So lots of upside to come.
As for NUMI, I would say when the tide rises in a sector it lifts all boats. At this point, I have not seen a single news release which justifies their price increase, but I would assume NUMI will benefit with the new incoming administration in the US as they seem friendly towards psychedelic research and the benefits of using MDMA-assisted therapy for treatment. So NUMI would benefit from this.